相似文献
1
Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies.
Heart. 2005 Jun;91(6):710-2. doi: 10.1136/hrt.2004.046839.
2
Rethinking continuing medical education.
BMJ. 2008 Aug 14;337:a973. doi: 10.1136/bmj.a973.
3
Truly independent research?
BMJ. 2008 Aug 21;337:a1332. doi: 10.1136/bmj.a1332.
4
Industry support of medical education.
JAMA. 2008 Sep 3;300(9):1071-3. doi: 10.1001/jama.300.9.1071.
5
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
Transfusion. 2012 Jun;52(6):e15-6. doi: 10.1111/j.1537-2995.2010.03014.x. Epub 2010 Dec 22.
6
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
Clin Chim Acta. 2011 Mar 18;412(7-8):491-2. doi: 10.1016/j.cca.2010.12.015. Epub 2010 Dec 14.
7
Spine surgeons: spine industry.
Eur Spine J. 2008 Jun;17(6):785-90; discussion 791-3. doi: 10.1007/s00586-007-0542-4. Epub 2007 Nov 20.
8
The ethics of industry support for professional education in medicine.
Indian J Med Ethics. 2008 Oct-Dec;5(4):177-80. doi: 10.20529/IJME.2008.066.
9
Individual wariness needed to spot biased drug research.
Manag Care. 2005 Sep;14(9):8, 13.
10
[Physicians and the drug industry. "To be like that, you'd better be married."].
Rev Calid Asist. 2009 Apr;24(2):47-50. doi: 10.1016/S1134-282X(09)70652-9.
引用本文的文献
1
SIR/RSNA/CIRSE Joint Medical Simulation Task Force strategic plan: executive summary.
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):551-4. doi: 10.1007/s00270-007-9103-9.
本文引用的文献
1
Continuing medical education in Europe: NVVC, CVOI, ESC, UEMS and EBAC.
Neth Heart J. 2001 Oct;9(7):288-291.
2
United Kingdom research governance strategy: reforming clinical research and development in England.
BMJ. 2004 Jan 3;328(7430):49-50; author reply 50. doi: 10.1136/bmj.328.7430.49-b.
3
Lessons from comparing CME accreditation in Europe and the United States.
Eur J Cancer. 2003 Nov;39(17):2422-3. doi: 10.1016/j.ejca.2003.09.011.
4
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Arch Intern Med. 2003 Oct 13;163(18):2213-8. doi: 10.1001/archinte.163.18.2213.
5
Industry sponsorship of continuing medical education.
JAMA. 2003 Sep 3;290(9):1149; author reply 1150. doi: 10.1001/jama.290.9.1149-a.
6
Current guidelines regarding industry-sponsored continuing medical education.
Clin Orthop Relat Res. 2003 Jul(412):21-7. doi: 10.1097/01.blo.0000074411.99625.55.
7
Guard dogs of perception: the corporate takeover of science.
Sci Eng Ethics. 2003 Jan;9(1):49-57. doi: 10.1007/s11948-003-0019-8.
8
[Sponsorship, conflict of interest and corruption: promoting science in discussion of medical ethics].
Wien Med Wochenschr. 2002;152(9-10):234-7. doi: 10.1046/j.1563-258x.2002.02034.x.
9
Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry.
Med J Aust. 2002 Feb 4;176(3):118-21. doi: 10.5694/j.1326-5377.2002.tb04318.x.
10
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med. 2002 Mar 21;346(12):877-83. doi: 10.1056/NEJMoa013474. Epub 2002 Mar 19.
Zotero 插件